Literature DB >> 1834671

Molecular cloning and characterization of a high affinity dopamine receptor (D1 beta) and its pseudogene.

R L Weinshank1, N Adham, M Macchi, M A Olsen, T A Branchek, P R Hartig.   

Abstract

We have cloned a novel human intronless gene encoding a G-protein-coupled receptor of the dopamine receptor family. Expression of this receptor in Cos-7 cells led to the high affinity binding of a number of dopamine D1 antagonists, with a binding profile similar to that of the previously described dopamine D1 receptor. In contrast, the agonist binding profile of this new receptor did not exactly match any previously defined dopamine D1 receptor and was notable for its unusually high affinity for dopamine. This new receptor caused a 13-fold increase in adenylylcyclase activity in transfected Cos-7 cells, following addition of dopamine. Messenger RNA encoding this new receptor appears to be widely distributed in the human brain, including cortical regions, choroid plexus, hippocampus, and brain stem. This new receptor appears to be identical to the recently described dopamine D5 receptor. A second closely related gene, GL39, was isolated and shown to represent a pseudogene, the first to be described in the G-protein-coupled receptor superfamily. This pseudogene exhibits 94% nucleotide sequence homology to the GL30 sequence and may have arisen from a gene duplication event followed by a mutation approximately 8 million years ago, prior to the emergence of man. This recently evolved pseudogene is transcribed in the human brain with a tissue distribution similar to that for its closely related functional gene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1834671

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Dopamine receptor genes: new tools for molecular psychiatry.

Authors:  H B Niznik; H H Van Tol
Journal:  J Psychiatry Neurosci       Date:  1992-10       Impact factor: 6.186

Review 2.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

3.  Distribution of D1 and D5 dopamine receptors in the primate and rat basolateral amygdala.

Authors:  E Chris Muly; Murat Senyuz; Zafar U Khan; Ji-Dong Guo; Rimi Hazra; Donald G Rainnie
Journal:  Brain Struct Funct       Date:  2009-08-08       Impact factor: 3.270

4.  Quantification of D1 and D5 dopamine receptor localization in layers I, III, and V of Macaca mulatta prefrontal cortical area 9: coexpression in dendritic spines and axon terminals.

Authors:  Jill R Bordelon-Glausier; Zafar U Khan; E Chris Muly
Journal:  J Comp Neurol       Date:  2008-06-20       Impact factor: 3.215

5.  D1A, D1B, and D1C dopamine receptors from Xenopus laevis.

Authors:  K S Sugamori; L L Demchyshyn; M Chung; H B Niznik
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

6.  Differential distributions and trafficking properties of dopamine D1 and D5 receptors in nerve cells.

Authors:  You He; Lei-Ping Yu; Guo-Zhang Jin
Journal:  Neurosci Bull       Date:  2009-04       Impact factor: 5.203

7.  Pharmacology and metabolism of renzapride : a novel therapeutic agent for the potential treatment of irritable bowel syndrome.

Authors:  Nicholas L Meyers; Roger I Hickling
Journal:  Drugs R D       Date:  2008

8.  Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia.

Authors:  C Schmauss; V Haroutunian; K L Davis; M Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

9.  Dopamine D1 and D5 receptors are localized to discrete populations of interneurons in primate prefrontal cortex.

Authors:  Jill R Glausier; Zafar U Khan; E Chris Muly
Journal:  Cereb Cortex       Date:  2008-11-19       Impact factor: 5.357

10.  Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients.

Authors:  Y T Kwak; M S Koo; C H Choi; I Sunwoo
Journal:  BMC Med Genet       Date:  2001-03-05       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.